Cargando…
Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes
Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important role in the pathophysiology of diseases associated with chronic inflammation. We demonstrate that patients with type-2 diabetes have increased plasma levels of ANXA1 when compared to normoglycemic subj...
Autores principales: | Purvis, Gareth S. D., Collino, Massimo, Loiola, Rodrigo A., Baragetti, Andrea, Chiazza, Fausto, Brovelli, Martina, Sheikh, Madeeha H., Collotta, Debora, Cento, Alessia, Mastrocola, Raffaella, Aragno, Manuela, Cutrin, Juan C., Reutelingsperger, Chris, Grigore, Liliana, Catapano, Alberico L., Yaqoob, Magdi M., Norata, Giuseppe Danilo, Solito, Egle, Thiemermann, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446914/ https://www.ncbi.nlm.nih.gov/pubmed/30972066 http://dx.doi.org/10.3389/fimmu.2019.00571 |
Ejemplares similares
-
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
por: Purvis, Gareth S. D., et al.
Publicado: (2017) -
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction
por: Chiazza, F., et al.
Publicado: (2017) -
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
por: Collotta, Debora, et al.
Publicado: (2020) -
Annexin-A1: Therapeutic Potential in Microvascular Disease
por: Purvis, Gareth S. D., et al.
Publicado: (2019) -
AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis
por: Stöhr, R., et al.
Publicado: (2018)